Its calculated from a foods calories and nutritional information, with saturated fat and added sugar raising the Points value and unsaturated fat, protein, and fibre driving it down
Additionally, there was a significantly lower risk of CRC in overweight and obese patients when treated with GLP-1RAs as compared with all antidiabetics examined in this study
Scheen AJ (2019) SGLT2 inhibitor or GLP-1 receptor agonist in type 2 diabetes
Upon food ingestion and its subsequent entry into the small intestine, intestinal L-cells undergo posttranslational processing of the proglucagon gene, leading to the production of glucagon-like peptide-1 (GLP-1), a potent incretin peptide hormone 9
Packages offer better long-term value
The published Phase 2 obesity trial used 24 weeks as the primary endpoint and 48 weeks as a secondary endpoint